Dividend guidance remains.
Drop in Esmya sales weigh on results.
Pharma company to publish earnings report early on Thursday.
Market expectations beaten by a mile.
Energy group expected to record robust figures.
It maintains profit guidance, though.
Chief Legal and Corporate Affairs Officer signing off.
Here are the results of Portfolio's monthly survey.
This time only 5,000, though.
60,000 shares this time.
That's way more than what analysts expect.
It has been for days.
Pharmafarm is back in business.
For HUF 479 million this time.
Signs license and distribution agreement.
Sertorius buys 63,000 OTP shares this time.
Sertorius Fund aquires more than 43,000 OTP shares.
Women's Healthcare portfolio expanded.
Rating remains unchanged.